Covered recipient · General Payments record
NICOLE M ROSS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$4,581.13
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,323.24 | 10 |
| Food and Beverage | $1,159.99 | 16 |
| Honoraria | $980.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $3,984.62 | 19 |
| REVANCE THERAPEUTICS, INC. | $417.61 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.16 | 1 |
| Merck Sharp & Dohme Corporation | $18.75 | 1 |
| Astellas Pharma US Inc | $17.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $17.09 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139557427 | CMS |
| Exelixis Inc. | $523.95 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573487 | CMS |
| Exelixis Inc. | $350.00 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573489 | CMS |
| Exelixis Inc. | $215.46 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573491 | CMS |
| Exelixis Inc. | $155.55 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138573493 | CMS |
| Exelixis Inc. | $55.38 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138573495 | CMS |
| Exelixis Inc. | $90.00 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138573497 | CMS |
| Exelixis Inc. | $16.21 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573499 | CMS |
| Exelixis Inc. | $56.00 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573501 | CMS |
| Exelixis Inc. | $39.76 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138573503 | CMS |
| Exelixis Inc. | $55.38 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138573505 | CMS |
| Exelixis Inc. | $16.21 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573509 | CMS |
| Exelixis Inc. | $350.00 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573511 | CMS |
| Exelixis Inc. | $215.46 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573513 | CMS |
| Exelixis Inc. | $155.55 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138573515 | CMS |
| Exelixis Inc. | $523.95 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573517 | CMS |
| Exelixis Inc. | $39.76 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138573519 | CMS |
| Exelixis Inc. | $56.00 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138573521 | CMS |
| Exelixis Inc. | $90.00 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138573523 | CMS |
| Exelixis Inc. | $980.00 | 07/03/2024 | Honoraria | Undisputed | 01/23/2026 | 1138573507 | CMS |
| Merck Sharp & Dohme LLC | $18.75 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141817781 | CMS |
| REVANCE THERAPEUTICS, INC. | $64.40 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147949978 | CMS |
| REVANCE THERAPEUTICS, INC. | $130.20 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147949980 | CMS |
| REVANCE THERAPEUTICS, INC. | $77.15 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147949982 | CMS |
| REVANCE THERAPEUTICS, INC. | $129.15 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147949984 | CMS |
| REVANCE THERAPEUTICS, INC. | $16.71 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147949986 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.16 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144982870 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.